Functional Contractile Characterization of Client Cell Lines
The Challenge
Pharma and biotech companies increasingly develop proprietary cardiomyocyte models, but often lack access to validated functional testing platforms. Without proper characterization under physiologically relevant conditions, it’s difficult to confirm performance, benchmark against standards, or detect unexpected liabilities in engineered lines.
Our Solution
We provide high-resolution functional analysis of client-derived cardiomyocyte lines using our FLEXcyte 96 mechanosensitive assay platform. Cells are assessed for attachment dynamics, contractile force development, rhythm, kinetics, and responsiveness to pharmacological challenge. Whether you're validating a new gene-edited model or conducting quality control across production lots, our platform delivers comprehensive functional phenotyping in a standardized, reproducible format.